PASITHEA THERAPEUTICS CORP. Increase (Decrease) in Prepaid Expense
PASITHEA THERAPEUTICS CORP. (KTTA) reported Increase (Decrease) in Prepaid Expense of $1.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was $626.88K, a 7.88% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $1.02M.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$474.55K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was -$15.70K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in prepaid expense for fiscal 2025 was $60.54K, a 30.21% decline from fiscal 2024.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in prepaid expense for fiscal 2024 was $86.75K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in prepaid expense for fiscal 2023 was -$346.48K, a 291.03% decline from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in prepaid expense for fiscal 2022 was $181.37K, a 44.95% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 5 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 8 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $626.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.64M 10-Q · filed 2026-08-14 | $1.17M derived: sum of 3 quarters · filed 2026-08-14 | $1.15M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2026-03-31 | $1.02M 10-Q · filed 2026-05-15 | $543.51K derived: sum of 2 quarters · filed 2026-05-15 | $527.81K derived: sum of 3 quarters · filed 2026-05-15 | $1.21M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-12-31 | -$474.55K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$490.25K derived: sum of 2 quarters · filed 2026-03-30 | $190.25K derived: sum of 3 quarters · filed 2026-08-14 | $60.54K 10-K · filed 2026-03-30 | ||||||
| 2025-09-30 | -$15.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $664.80K derived: sum of 2 quarters · filed 2026-08-14 | $535.09K 10-Q · filed 2025-11-13 | $518.46K derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-06-30 | $680.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $550.78K 10-Q · filed 2026-08-14 | $534.16K derived: sum of 3 quarters · filed 2026-08-14 | $283.18K derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-03-31 | -$129.71K 10-Q · filed 2026-05-15 | -$146.34K derived: sum of 2 quarters · filed 2026-05-15 | -$397.31K derived: sum of 3 quarters · filed 2026-05-15 | -$865.47K derived: sum of 4 quarters · filed 2026-05-15 | ||||||
| 2024-12-31 | -$16.63K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$267.60K derived: sum of 2 quarters · filed 2026-03-30 | -$735.76K derived: sum of 3 quarters · filed 2026-03-30 | $86.75K 10-K · filed 2026-03-30 | ||||||
| 2024-09-30 | -$250.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$719.13K derived: sum of 2 quarters · filed 2025-11-13 | $103.38K 10-Q · filed 2025-11-13 | -$665.80K derived: sum of 4 quarters · filed 2025-11-13 | ||||||
| 2024-06-30 | -$468.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $354.35K 10-Q · filed 2025-08-14 | -$414.82K derived: sum of 3 quarters · filed 2025-08-14 | -$244.33K derived: sum of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | $822.51K 10-Q · filed 2025-05-15 | $53.34K derived: sum of 2 quarters · filed 2025-05-15 | $223.83K derived: sum of 3 quarters · filed 2025-05-15 | $202.63K derived: sum of 4 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | -$769.17K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$598.68K derived: sum of 2 quarters · filed 2025-03-24 | -$619.88K derived: sum of 3 quarters · filed 2025-03-24 | -$346.48K 10-K · filed 2025-03-24 | ||||||
| 2023-09-30 | $170.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $149.29K derived: sum of 2 quarters · filed 2024-11-13 | $422.69K 10-Q · filed 2024-11-13 | -$65.56K derived: sum of 4 quarters · filed 2024-11-13 | ||||||
| 2023-06-30 | -$21.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $252.20K 10-Q · filed 2024-08-13 | -$236.06K derived: sum of 3 quarters · filed 2024-08-13 | $295.82K derived: sum of 4 quarters · filed 2024-08-13 | ||||||
| 2023-03-31 | $273.40K 10-Q · filed 2024-05-14 | -$214.85K derived: sum of 2 quarters · filed 2024-05-14 | $317.02K derived: sum of 3 quarters · filed 2024-05-14 | $216.31K derived: sum of 4 quarters · filed 2024-05-14 | ||||||
| 2022-12-31 | -$488.25K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $43.62K derived: sum of 2 quarters · filed 2024-03-29 | -$57.09K derived: sum of 3 quarters · filed 2024-03-29 | $181.37K 10-K · filed 2024-03-29 | $244.53K 10-K · filed 2023-03-30 | |||||
| 2022-09-30 | $531.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $431.17K derived: sum of 2 quarters · filed 2023-11-13 | $669.63K 10-Q · filed 2023-11-13 | $822.04K 10-Q · filed 2022-11-14 | $534.85K derived: sum of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | -$100.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $137.75K 10-Q · filed 2023-08-11 | $211.48K 10-Q · filed 2022-08-15 | $2.98K derived: sum of 3 quarters · filed 2023-08-11 | $398.59K derived: sum of 4 quarters · filed 2023-08-11 | |||||
| 2022-03-31 | $238.46K 10-Q · filed 2023-05-12 | $294.99K 10-Q · filed 2022-05-16 | $103.69K derived: sum of 2 quarters · filed 2023-05-12 | $499.30K derived: sum of 3 quarters · filed 2023-05-12 | $502.82K derived: sum of 4 quarters · filed 2023-05-12 | |||||
| 2021-12-31 | -$134.78K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $260.83K derived: sum of 2 quarters · filed 2023-03-30 | $264.36K derived: sum of 3 quarters · filed 2023-03-30 | $329.44K 10-K · filed 2023-03-30 | ||||||
| 2021-09-30 | $395.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $399.13K derived: sum of 2 quarters · filed 2022-11-14 | $464.22K 10-Q · filed 2022-11-14 | $496.75K 10-Q · filed 2021-11-18 | ||||||
| 2021-06-30 | $3.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $68.61K 10-Q · filed 2022-08-15 | ||||||||
| 2021-03-31 | $65.09K 10-Q · filed 2022-05-16 | |||||||||
| 2020-12-31 | $4.31K 10-K · filed 2022-03-30 | |||||||||
| 2020-09-30 | $10.00K 10-Q · filed 2021-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |